C3.ai Inc vs 10X Genomics Inc — how do they compare? C3.ai Inc trades at $10.55 (market cap $1.65B), while 10X Genomics Inc trades at $58.56 (market cap $7.61B). The key difference: 10X Genomics Inc is far larger — about 4.6× C3.ai Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, C3.ai Inc nearer its low. Which is the better fit depends on your goals.
| AI | TXG | |
|---|---|---|
Market Cap | $1.65B | $7.61B |
Sector | Technology | Health |
52-Week High | $19.66 | $58.57 |
52-Week Low | $7.76 | $11.34 |
Enterprise Value | $1.08B | $7.14B |
Trailing returns across standard periods
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →